Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2013 Feb 1;2(2):e22679.
doi: 10.4161/onci.22679.

Uncovering the mechanisms that regulate tumor-induced T-cell anergy

Affiliations

Uncovering the mechanisms that regulate tumor-induced T-cell anergy

Brian T Abe et al. Oncoimmunology. .

Abstract

Helper T cells become hyporesponsive in the tumor microenvironment (at least in part) owing to the NFAT1-dependent expression of anergy-associated genes. Anergy constitutes a crucial mechanism to prevent tumor destruction by T cells, and hence may represent a powerful target to boost antitumor immune responses and improve the efficacy of immunotherapy.

Keywords: NFAT; T helper cell; anergy; immune evasion; melanoma.

PubMed Disclaimer

Figures

None
Figure 1. Tumor-induced helper T-cell anergy. The immunosuppressive tumor microenvironment induces anergy in helper T cells through the NFAT-dependent expression of anergy-inducing genes, coding for proteins that can inhibit TCR signaling and silence cytokine expression. The activation of this program can be caused by interferences with dendritic cell (DC) maturation, which might result in defective co-stimulation, although a direct role for other cells in the tumor microenvironment cannot be excluded. Anergic CD4+ T cells cannot efficiently “help” CD8+ T-cell antitumor responses, allowing cancer cells to escape CD8+ T cell-mediated lytic responses.

References

    1. Gajewski TF. Failure at the effector phase: immune barriers at the level of the melanoma tumor microenvironment. Clin Cancer Res. 2007;13:5256–61. doi: 10.1158/1078-0432.CCR-07-0892. - DOI - PubMed
    1. Staveley-O’Carroll K, Sotomayor E, Montgomery J, Borrello I, Hwang L, Fein S, et al. Induction of antigen-specific T cell anergy: An early event in the course of tumor progression. Proc Natl Acad Sci U S A. 1998;95:1178–83. doi: 10.1073/pnas.95.3.1178. - DOI - PMC - PubMed
    1. Jenkins MK, Chen CA, Jung G, Mueller DL, Schwartz RH. Inhibition of antigen-specific proliferation of type 1 murine T cell clones after stimulation with immobilized anti-CD3 monoclonal antibody. J Immunol. 1990;144:16–22. - PubMed
    1. Macián F, García-Cózar F, Im SH, Horton HF, Byrne MC, Rao A. Transcriptional mechanisms underlying lymphocyte tolerance. Cell. 2002;109:719–31. doi: 10.1016/S0092-8674(02)00767-5. - DOI - PubMed
    1. Chiodetti L, Choi S, Barber DL, Schwartz RH. Adaptive tolerance and clonal anergy are distinct biochemical states. J Immunol. 2006;176:2279–91. - PubMed